Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2022-10-09 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
R&D Refund 2 pages 173.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 10 October 2022, confirming receipt of a $1.6M Research and Development Tax Incentive refund for the year ended 31 December 2021. It is a brief announcement about a government tax refund related to R&D activities, with no financial statements or detailed financial performance data. The document length is 2641 characters, which is relatively short and does not contain a full report or detailed financial analysis. It is not a report itself but an announcement of a financial event (receipt of a tax refund). Therefore, it fits best under the category of a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2022-10-09 English
Notification of cessation of securities - AVR 5 pages 25.7KB
Regulatory Filings Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the expiry of options and convertible securities for Anteris Technologies Ltd. It provides specific information about securities that have ceased, including quantities, reasons for cessation, and updated issued capital figures. The document is a formal announcement to the ASX about changes in the company's issued capital due to expiry of securities. It does not contain financial statements, management discussion, or detailed financial results. It is not an annual or interim report, nor a call transcript or audit report. It is a regulatory announcement about changes in securities status, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-09-26 English
Notification of cessation of securities - AVR 5 pages 26.2KB
Regulatory Filings Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the lapse of certain options (unquoted equity securities) for Anteris Technologies Ltd. It provides specific information about the securities that have ceased, the reasons for cessation, and the updated issued capital following these changes. There is no indication of financial statements, management discussion, or earnings data. The document is a regulatory announcement about changes in the company's issued securities, specifically the cessation of certain options. This fits best under the category of Regulatory Filings (RNS), as it is a general regulatory announcement about securities status changes and does not fit into more specific categories like Share Issue/Capital Change (SHA) which typically involves new issues or capital increases rather than cessation or lapsing of securities. The document length (5644 characters) and content confirm it is a full announcement rather than a brief notice or a report publication announcement. Therefore, the classification is Regulatory Filings (RNS).
2022-09-22 English
Notification regarding unquoted securities - AVR 9 pages 32.9KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted securities under an employee incentive scheme by Anteris Technologies Ltd. It includes specifics such as security descriptions, issue dates, numbers issued, and mentions key management personnel receiving securities. The document is a formal announcement of securities issuance rather than a financial report or earnings release. It does not contain financial statements or management discussion but focuses on capital changes related to securities issuance. Therefore, it fits the category of 'Share Issue/Capital Change' (SHA). The document length (8270 characters) supports it being a full announcement rather than a brief notice or a report publication announcement.
2022-09-22 English
Anteris Investor Webinar 36 pages 4.5MB
Regulatory Filings
2022-09-19 English
Results Demonstrating Restoration of Normal Pre-Disease Flow 2 pages 172.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 19 September 2022 presenting preliminary clinical results related to aortic valve replacement technology. It discusses study findings and product performance but does not contain detailed financial data, comprehensive financial statements, or regulatory filings. The document is relatively short (3363 characters) and reads as a news release or update rather than a formal financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Audit Report. It is not a management or investor presentation, nor does it announce voting results, capital changes, or legal proceedings. The content is primarily a clinical and product update announcement. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other specific categories.
2022-09-18 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.